AI-designed drug appears to turn back the body's biological clock in early trial
This story is from 2026-09-07. It is preserved in the archive; the latest stories are on the live feed.
A study in Nature Biotechnology suggests that rentosertib, a drug designed with AI by Insilico Medicine, may reverse markers of biological aging. Six independent aging clocks predicted that treated patients were biologically up to six years younger than the placebo group. The trial covered just 42…
Read the full story at The Decoder ↗
Timeline · 1 report
- 2026-09-07 16:34 · The Decoder
AI-designed drug appears to turn back the body's biological clock in early trial